Press release 27. July 2010: ProtAffin AG signs manufacturing contract for PA401 with CMC Biologics A/S
Press release in English
Press release 11. September 2009: ProtAffin AG granted patent in USA for lead anti-inflammatory product PA401 Press release in English
Press release 27. April 2009: ProtAffin AG completes €14 million Series B financing Press release in English Press release in German
Press release 23. January 2009: ProtAffin AG granted patent in EU for lead anti-inflammatory product PA401 Press release in English
Press release 5. September 2008: ProtAffin AG receives Orphan Drug Designation in US from FDA for PA401 Press release in English
Press release 18. July 2008: ProtAffin AG receives Orphan Medicinal Product Designation from EMEA for PA401 Press release in English Press release in German
Press release in English Press release in German
